The Next Frontier for GLP-1 Medications: Potential Therapy for Inflammation

A study in Cell Metabolism suggests semaglutide may reduce osteoarthritis inflammation, tissue damage, pain sensitivity, and cartilage breakdown.

The effects appeared independent of weight loss, strengthening evidence that GLP-1 drugs may help conditions beyond obesity.

The findings point to a possible new role for GLP-1 medications in chronic inflammatory joint disease.

Access and insurance coverage remain major hurdles for patients who might benefit from these drugs.